Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares are ticking to intra-session lows Monday following an update on its Marburg treatment candidate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE